Abderrahmani, Amar http://orcid.org/0000-0003-0752-0343
Yengo, Loïc
Caiazzo, Robert
Canouil, Mickaël
Cauchi, Stéphane
Raverdy, Violeta
Plaisance, Valérie
Pawlowski, Valérie
Lobbens, Stéphane
Maillet, Julie
Rolland, Laure
Boutry, Raphael
Queniat, Gurvan
Kwapich, Maxime
Tenenbaum, Mathie
Bricambert, Julien
Saussenthaler, Sophie
Anthony, Elodie
Jha, Pooja
Derop, Julien
Sand, Olivier
Rabearivelo, Iandry
Leloire, Audrey
Pigeyre, Marie
Daujat-Chavanieu, Martine
Gerbal-Chaloin, Sabine
Dayeh, Tasnim
Lassailly, Guillaume
Mathurin, Philippe
Staels, Bart
Auwerx, Johan
Schürmann, Annette
Postic, Catherine
Schafmayer, Clemens
Hampe, Jochen
Bonnefond, Amélie
Pattou, François
Froguel, Philippe
Clinical trials referenced in this document:
Documents that mention this clinical trial
Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes (Results)
https://doi.org/10.2337/db17-1539
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-10-LABX-46, ANR-10-EQPX-07-01)
H2020 European Research Council (GEPIDIAB - 294785)